Scott Ryan - Gentex Gen VP
| GTX Stock | EUR 28.00 0.20 0.71% |
Insider
Scott Ryan is Gen VP of Gentex
| Age | 42 |
| Phone | 616 772 1800 |
| Web | https://www.gentex.com |
Scott Ryan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Scott Ryan against Gentex stock is an integral part of due diligence when investing in Gentex. Scott Ryan insider activity provides valuable insight into whether Gentex is net buyers or sellers over its current business cycle. Note, Gentex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Gentex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Scott Ryan over six months ago Disposition of 5570 shares by Scott Ryan of Gentex at 28.2919 subject to Rule 16b-3 |
Gentex Management Efficiency
The company has return on total asset (ROA) of 0.1037 % which means that it generated a profit of $0.1037 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1592 %, meaning that it generated $0.1592 on every $100 dollars invested by stockholders. Gentex's management efficiency ratios could be used to measure how well Gentex manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Gerald Shreiber | JJ SNACK FOODS | 81 | |
| Martina Widman | Diamyd Medical AB | 42 | |
| Michael Pollner | JJ SNACK FOODS | 50 | |
| John Griffith | JJ SNACK FOODS | N/A | |
| Daniel Fachner | JJ SNACK FOODS | 63 | |
| Robert Cranmer | JJ SNACK FOODS | N/A | |
| Stephen Every | JJ SNACK FOODS | 61 | |
| Anna BSc | Diamyd Medical AB | 62 | |
| Mary Kehoe | JJ SNACK FOODS | N/A | |
| Douglas Davidson | JJ SNACK FOODS | N/A | |
| Lynwood Mallard | JJ SNACK FOODS | 55 | |
| Eva Karlstrom | Diamyd Medical AB | 59 | |
| Ken Plunk | JJ SNACK FOODS | 60 | |
| Anton Lindqvist | Diamyd Medical AB | 43 | |
| Christoph Nowak | Diamyd Medical AB | 37 | |
| Ulf MBA | Diamyd Medical AB | 48 | |
| Marjorie Esq | JJ SNACK FOODS | 54 | |
Management Performance
Gentex Leadership Team
Elected by the shareholders, the Gentex's board of directors comprises two types of representatives: Gentex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gentex. The board's role is to monitor Gentex's management team and ensure that shareholders' interests are well served. Gentex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gentex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fred Bauer, Chairman Founder | ||
| Matthew Chiodo, VP Officer | ||
| Joseph IV, VP Officer | ||
| Steven Downing, CEO Pres | ||
| Neil Boehm, CTO Engineering | ||
| Scott Ryan, Gen VP | ||
| Kevin Nash, CFO, Fin | ||
| Craig Piersma, VP Communications | ||
| Paul Flynn, VP Operations | ||
| Josh OBerski, Director Relations |
Gentex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Gentex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 5.92 B | |||
| Shares Outstanding | 234.18 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 88.91 % | |||
| Price To Earning | 20.28 X | |||
| Price To Book | 3.16 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Gentex Stock
When determining whether Gentex offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Gentex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Gentex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Gentex Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gentex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Gentex Stock please use our How to Invest in Gentex guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.